$53.2 Million is the total value of Richmond Brothers, Inc.'s 24 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 18.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| QQQ | Sell | INVESCO QQQ TRunit ser 1 | $16,717,595 | -11.6% | 46,638 | -8.8% | 31.40% | +2.5% |
| MDXG | Sell | MIMEDX GROUP INC | $10,798,962 | +3.0% | 1,481,332 | -6.6% | 20.28% | +19.4% |
| AAPL | Sell | APPLE INC | $5,890,162 | -20.9% | 34,395 | -10.4% | 11.06% | -8.3% |
| BRKB | Sell | BERKSHIRE HATHAWAY INC DELcl b new | $5,409,443 | -12.9% | 15,440 | -15.3% | 10.16% | +1.0% |
| GOF | Buy | GUGGENHEIM STRATEGIC OPPORTU | $3,855,839 | -6.2% | 260,700 | +0.8% | 7.24% | +8.7% |
| MSFT | Sell | MICROSOFT CORP | $1,657,990 | -32.1% | 5,247 | -26.8% | 3.11% | -21.2% |
| ARKK | Sell | ARK ETF TRinnovation etf | $1,529,326 | -30.9% | 38,540 | -23.1% | 2.87% | -19.9% |
| IBB | Sell | ISHARES TRishares biotech | $1,420,666 | -16.6% | 11,616 | -13.4% | 2.67% | -3.2% |
| OCUP | Buy | OCUPHIRE PHARMA INC | $1,232,812 | -16.9% | 368,003 | +7.6% | 2.32% | -3.6% |
| Sell | ROCKWELL MED INC | $853,535 | -63.0% | 410,352 | -2.9% | 1.60% | -57.1% | |
| NVG | Sell | NUVEEN AMT FREE MUN CR INC F | $591,155 | -19.1% | 57,336 | -8.2% | 1.11% | -6.2% |
| AMZN | Buy | AMAZON COM INC | $490,047 | +0.0% | 3,855 | +2.6% | 0.92% | +16.0% |
| IVV | Buy | ISHARES TRcore s&p500 etf | $394,646 | -2.2% | 919 | +1.5% | 0.74% | +13.5% |
| MCD | Sell | MCDONALDS CORP | $339,490 | -26.3% | 1,287 | -16.5% | 0.64% | -14.4% |
| Sell | AIR INDS GROUP | $319,841 | -29.6% | 111,319 | -13.0% | 0.60% | -18.2% | |
| APLT | New | APPLIED THERAPEUTICS INC | $307,898 | – | 123,654 | +100.0% | 0.58% | – |
| AXNX | New | AXONICS INC | $266,514 | – | 4,749 | +100.0% | 0.50% | – |
| GOOG | Sell | ALPHABET INCcap stk cl c | $261,063 | -43.2% | 1,980 | -47.9% | 0.49% | -34.1% |
| PG | Sell | PROCTER AND GAMBLE CO | $226,010 | -7.1% | 1,549 | -3.3% | 0.42% | +7.6% |
| JNJ | JOHNSON & JOHNSON | $210,318 | -5.9% | 1,349 | 0.0% | 0.40% | +9.1% | |
| VZ | Sell | VERIZON COMMUNICATIONS INC | $205,585 | -22.7% | 6,342 | -11.3% | 0.39% | -10.4% |
| ONCT | Buy | ONCTERNAL THERAPEUTICS INC | $148,212 | +47.6% | 494,042 | +69.8% | 0.28% | +70.6% |
| HRTX | Buy | HERON THERAPEUTICS INC | $106,100 | +115.7% | 103,009 | +142.9% | 0.20% | +148.8% |
| New | CHARGE ENTERPRISES INC | $9,944 | – | 20,000 | +100.0% | 0.02% | – | |
| PSP | Exit | INVESCO EXCHANGE TRADED FD Tgbl listed pvt | $0 | – | -52,889 | -100.0% | -0.90% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-03
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INVESCO QQQ TR | 8 | Q3 2023 | 36.9% |
| BERKSHIRE HATHAWAY INC DEL | 8 | Q3 2023 | 15.0% |
| APPLE INC | 8 | Q3 2023 | 13.8% |
| MIMEDX GROUP INC | 8 | Q3 2023 | 20.3% |
| GUGGENHEIM STRATEGIC OPPORTU | 8 | Q3 2023 | 9.5% |
| ISHARES TR | 8 | Q3 2023 | 6.3% |
| ARK ETF TR | 8 | Q3 2023 | 4.0% |
| MICROSOFT CORP | 8 | Q3 2023 | 4.0% |
| NUVEEN AMT FREE MUN CR INC F | 8 | Q3 2023 | 2.8% |
| OCUPHIRE PHARMA INC | 8 | Q3 2023 | 2.4% |
View Richmond Brothers, Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ROCKWELL MEDICAL, INC. | September 06, 2023 | 55,510 | 0.0% |
| ROCKWELL MEDICAL, INC. | February 23, 2023 | 519,980 | 4.5% |
| Ocuphire Pharma, Inc. | May 17, 2022 | 1,123,539 | 5.8% |
| AIR INDUSTRIES GROUP | October 22, 2021 | 2,242,374 | 6.9% |
| FIRMA HOLDINGS CORP. | October 26, 2016 | 30,006,694 | 25.1% |
View Richmond Brothers, Inc.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-08 |
| 13F-HR | 2023-11-03 |
| SC 13D/A | 2023-09-06 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-10 |
| SC 13G | 2023-02-23 |
| 13F-HR | 2023-02-08 |
| 13F-HR | 2022-11-02 |
| 13F-HR | 2022-08-12 |
| SC 13D/A | 2022-06-23 |
View Richmond Brothers, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.